Citations (57)
Keep up to date with the latest research on this topic with citation updates for this article.
Articles from other publishers (57)
Michał Tomaszewski, Paulina Mertowska, Martyna Janczewska, Agnieszka Styczeń, Sebastian Mertowski, Kamil Jonas, Ewelina Grywalska & Grzegorz Kopeć. (2023) In the Search for Biomarkers of Pulmonary Arterial Hypertension, Are Cytokines IL-2, IL-4, IL-6, IL-10, and IFN-Gamma the Right Indicators to Use?. International Journal of Molecular Sciences 24:18, pages 13694.
Crossref
Crossref
Barney Viengkhou & Markus J. Hofer. (2023) Breaking down the cellular responses to type I interferon neurotoxicity in the brain. Frontiers in Immunology 14.
Crossref
Crossref
I. E. Chazova, F. T. Ageev, A. V. Aksenova, M. V. Vicenya, M. Yu. Gilyarov, T. V. Martynyuk, E. P. Panchenko, M. G. Poltavskaya, V. I. Potievskaya, O. P. Trofimova & Yu. A. Fedotkina. (2022) Eurasian clinical guidelines for cardiovascular complications of cancer treatments: diagnosis, prevention and treatment (2022). Eurasian heart journal:1, pages 6-79.
Crossref
Crossref
Yolanda Bryce, Ernesto Santos-Martin, Etay Ziv, Adrian Gonzalez-Aguirre, Amgad Moussa, Adie Friedman & Majid Maybody. (2022) Abnormal photoplethysmography waveforms are associated with chemotherapy induced neuropathy. Vasa 51:2, pages 85-92.
Crossref
Crossref
Yong-Jie Chen, Yi Li, Xian Guo, Bo Huo, Yue Chen, Yi He, Rui Xiao, Xue-Hai Zhu, Ding-Sheng Jiang & Xiang Wei. (2021) Upregulation of IRF9 Contributes to Pulmonary Artery Smooth Muscle Cell Proliferation During Pulmonary Arterial Hypertension. Frontiers in Pharmacology 12.
Crossref
Crossref
Michał Tomaszewski, Dominika Bębnowska, Rafał Hrynkiewicz, Jakub Dworzyński, Paulina Niedźwiedzka-Rystwej, Grzegorz Kopeć & Ewelina Grywalska. (2021) Role of the Immune System Elements in Pulmonary Arterial Hypertension. Journal of Clinical Medicine 10:16, pages 3757.
Crossref
Crossref
Joerg Herrmann. (2019) Common Vascular Toxicities of Cancer Therapies. Cardiology Clinics 37:4, pages 365-384.
Crossref
Crossref
Epp Kaleviste, Mario Saare, Timothy Ronan Leahy, Vincent Bondet, Darragh Duffy, Trine H. Mogensen, Sofie E Jørgensen, Helke Nurm, Winnie Ip, E Graham Davies, Sascha Sauer, Ann‐Christine Syvänen, Lili Milani, Pärt Peterson & Kai Kisand. (2019)
Interferon signature in patients with
STAT1
gain‐of‐function mutation is epigenetically determined
. European Journal of Immunology 49:5, pages 790-800.
Crossref
Crossref
Douglas N. Fish. 2018. Drug Interactions in Infectious Diseases: Antimicrobial Drug Interactions. Drug Interactions in Infectious Diseases: Antimicrobial Drug Interactions
381
424
.
I Ye Chazova, S A Tyulyandin, M V Vitsenia, M G Poltavskaya, M Yu Gilyarov, T V Martynyuk, A G Ovchinnikov, E P Panchenko, Yu A Fedotkina, M B Stenina, O P Trophimova & F T Ageev. (2017) Clinical Manual for Diagnosis, Prevention and Treatment of Cardiovascular Complications of Cancer Therapy. Parts II-V. Systemic Hypertension 14:4, pages 6-19.
Crossref
Crossref
Thilo Gambichler, Stefanie Strutzmann, Andrea Tannapfel & Laura Susok. (2017) Paraneoplastic acral vascular syndrome in a patient with metastatic melanoma under immune checkpoint blockade. BMC Cancer 17:1.
Crossref
Crossref
Gwenalyn Garcia & Jean Paul Atallah. (2016) Antineoplastic agents and thrombotic microangiopathy. Journal of Oncology Pharmacy Practice 23:2, pages 135-142.
Crossref
Crossref
Samera Vaseer & Eliza F. Chakravarty. 2017. Kelley and Firestein's Textbook of Rheumatology. Kelley and Firestein's Textbook of Rheumatology
2048
2065.e6
.
Sareh Shahmohammadi, Seyed Ehsan Mohammadianinejad, Mohammad Ali Sahraian & Abdorreza Naser Moghadasi. (2016) Intracerebral Hemorrhage in a Patient with Multiple Sclerosis Receiving Interferon Beta-1α. Archives of Neuroscience Inpress:Inpress.
Crossref
Crossref
Mathieu P. Rodero & Yanick J. Crow. (2016) Type I interferon–mediated monogenic autoinflammation: The type I interferonopathies, a conceptual overview. Journal of Experimental Medicine 213:12, pages 2527-2538.
Crossref
Crossref
Sarah L. Pogue, Tetsuya Taura, Mingying Bi, Yong Yun, Angela Sho, Glen Mikesell, Collette Behrens, Maya Sokolovsky, Hussein Hallak, Moti Rosenstock, Eric Sanchez, Haiming Chen, James Berenson, Anthony Doyle, Steffen Nock & David S. Wilson. (2016) Targeting Attenuated Interferon-α to Myeloma Cells with a CD38 Antibody Induces Potent Tumor Regression with Reduced Off-Target Activity. PLOS ONE 11:9, pages e0162472.
Crossref
Crossref
Charles Khouri, Sophie Blaise, Patrick Carpentier, Céline Villier, Jean-Luc Cracowski & Matthieu Roustit. (2016) Drug-induced Raynaud's phenomenon: beyond β-adrenoceptor blockers. British Journal of Clinical Pharmacology 82:1, pages 6-16.
Crossref
Crossref
Oksana Hamidi, Jochen Reiser & Scott Hasler. (2016) An Interferon-Induced Digital Vasculitis-Like Syndrome. American Journal of Therapeutics 23:3, pages e920-e925.
Crossref
Crossref
Joerg HerrmannEric H. YangCezar A. IliescuMehmet CilingirogluKonstantinos CharitakisAbdul HakeemKonstantinos ToutouzasMassoud A. LeesarCindy L. GrinesKonstantinos Marmagkiolis. (2016) Vascular Toxicities of Cancer Therapies. Circulation 133:13, pages 1272-1289.
Crossref
Crossref
Ibtesam Ibrahim El-Dosouky, Soha Abdel-Moneim El Hawari, Mohamed Hassan Emara & Emad Fawzi Hamed. (2016) Types and predictors of interferon/ribavirin induced cardiac complications in the Egyptian patients with chronic hepatitis C virus. Journal of Indian College of Cardiology 6:1, pages 16-21.
Crossref
Crossref
. 2016. Meyler's Side Effects of Drugs. Meyler's Side Effects of Drugs
158
208
.
Joerg Herrmann & Amir Lerman. 2016. Clinical Cardio-Oncology. Clinical Cardio-Oncology
163
184
.
Laurent Savale, Caroline Sattler, Sven Günther, David Montani, Marie-Camille Chaumais, Swanny Perrin, Xavier Jaïs, Andrei Seferian, Roland Jovan, Sophie Bulifon, Florence Parent, Gérald Simonneau, Marc Humbert & Olivier Sitbon. (2014) Pulmonary arterial hypertension in patients treated with interferon. European Respiratory Journal 44:6, pages 1627-1634.
Crossref
Crossref
Reza Vosoughi & James J. Marriott. (2014) Thrombotic microangiopathy in Interferon Beta treated multiple sclerosis patients: Review of literature and report of two new cases. Multiple Sclerosis and Related Disorders 3:3, pages 321-325.
Crossref
Crossref
Peter M. GeorgeEduardo OliverPeter DorfmullerOlivier D. DuboisDaniel M. ReedNicholas S. KirkbyNura A. MohamedFrederic PerrosFabrice AntignyElie FadelBenjamin E. SchreiberAlan M. HolmesMark SouthwoodGuy HaganStephen J. WortNathan BartlettNicholas W. MorrellJohn G. CoghlanMarc HumbertLan ZhaoJane A. Mitchell. (2014) Evidence for the Involvement of Type I Interferon in Pulmonary Arterial Hypertension. Circulation Research 114:4, pages 677-688.
Crossref
Crossref
Nishant Poddar & Jen C. Wang. (2013) Thrombotic Thrombocytopenic Purpura in a Patient with Interferon Treated Hepatitis C Successfully Treated with Rituximab. Hematology Reports 5:1, pages e2.
Crossref
Crossref
Eliza F. Chakravarty. 2013. Kelley's Textbook of Rheumatology. Kelley's Textbook of Rheumatology
1934
1950.e6
.
Peter M. George, Rekha Badiger, William Alazawi, Graham R. Foster & Jane A. Mitchell. (2012) Pharmacology and therapeutic potential of interferons. Pharmacology & Therapeutics 135:1, pages 44-53.
Crossref
Crossref
Mi Jin HongHong Ghi LeeMina HurSung Yong KimYo Han ChoSo Young Yoon. (2011) Slow, but complete, resolution of mitomycin-induced refractory thrombotic thrombocytopenic purpura after rituximab treatment. The Korean Journal of Hematology 46:1, pages 45.
Crossref
Crossref
Jana G Hashash. (2011) Digital ischemic necrosis caused by pegylated interferon in a patient with hepatitis C. World Journal of Gastrointestinal Pharmacology and Therapeutics 2:1, pages 6.
Crossref
Crossref
Douglas N. Fish. 2011. Drug Interactions in Infectious Diseases. Drug Interactions in Infectious Diseases
471
508
.
Kim Bouillon, Yola Moride, Lamiae Bensouda-Grimaldi & Lucien Abenhaim. 2011. Textbook of Pulmonary Vascular Disease. Textbook of Pulmonary Vascular Disease
1043
1059
.
. (2010) Drug Allergy: An Updated Practice Parameter. Annals of Allergy, Asthma & Immunology 105:4, pages 259-273.e78.
Crossref
Crossref
Margreet A. Veening, Jonathan I. Verbeke, Melinda M. Witbreuk & Gert-Jan L. Kaspers. (2010) Kaposiform (Spindle Cell) Hemangioendotelioma in a Child With an Unusual Presentation. Journal of Pediatric Hematology/Oncology 32:3, pages 240-242.
Crossref
Crossref
Ophira Salomon, Tali Tohami, Luba Trakhtenbrot, Rita Meirov, Abraham Kneller, Miriam Berkowitz, Arnon Nagler, Eyal Sivan, John M. Goldman, Gideon Rechavi & Ninette Amariglio. (2010) BCR-ABL transcripts are not detected in cord blood or the peripheral blood of the newborn child whose mother developed chronic myeloid leukemia while pregnant. Leukemia Research 34:2, pages e78-e81.
Crossref
Crossref
Gregory J. Landry. 2010. Rutherford's Vascular Surgery. Rutherford's Vascular Surgery
1822
1845
.
AH Ledinek, SŠ Jazbec, I Drinovec & U Rot. (2009) Pulmonary arterial hypertension associated with interferon beta treatment for multiple sclerosis: a case report. Multiple Sclerosis Journal 15:7, pages 885-886.
Crossref
Crossref
Georges-Philippe Pageaux, Marie-Noelle Hilleret, Valérie Garrigues, Michael Bismuth, Héla Audin-Mamlouk, Jean-Pierre Zarski & Georges Mourad. (2009) Pegylated interferon-α-based treatment for chronic hepatitis C in renal transplant recipients: an open pilot study. Transplant International 22:5, pages 562-567.
Crossref
Crossref
. 2009. MeylerâÂÂs Side Effects of Cardiovascular Drugs. MeylerâÂÂs Side Effects of Cardiovascular Drugs
557
820
.
Anaadriana Zakarija. 2009. Coagulation in Cancer. Coagulation in Cancer
115
136
.
Alexander Panda, John McArdle & Adrian C. Borges. (2008) NONREVERSIBLE INTERFERON-ALPHA-INDUCED PULMONARY ARTERIAL HYPERTENSION REQUIRING CONTINUOUS VASODILATOR THERAPY. Chest 134:4, pages 16C.
Crossref
Crossref
Axel Hauschild, Katharina C. Kähler, Martin Schäfer & Michael Fluck. (2008) Interdisciplinary management recommendations for toxicity associated with interferon-alfa therapy. JDDG 0:0, pages 080326230128326-???.
Crossref
Crossref
Axel Hauschild, Helen Gogas, Ahmad Tarhini, Mark R. Middleton, Alessandro Testori, Brigitte Dréno & John M. Kirkwood. (2008) Practical guidelines for the management of interferon‐α‐2b side effects in patients receiving adjuvant treatment for melanoma. Cancer 112:5, pages 982-994.
Crossref
Crossref
Yun Jong Lee, Seong Wook Kang, Ju Kyoung Song, Han Joo Baek, Hyo Jin Choi, Young Deok Bae, Hee Jung Ryu, Eun Young Lee, Eun Bong Lee & Yeong Wook Song. (2007) Associations between interferon regulatory factor–1 polymorphisms and Behçet’s disease. Human Immunology 68:9, pages 770-778.
Crossref
Crossref
Alfons Serrano, Blanca Xicoy, Juan Ramón Grifols & Josep-Maria Ribera. (2007) Púrpura trombótica trombocitopénica durante el tratamiento con interferón. Medicina Clínica 128:7, pages 276-277.
Crossref
Crossref
I. Zaraa, E. Maubec, L. Valeyrie-Allanore, M. Essig, A. Charachon, D. Chosidow, M.-P. Debray, E. Marinho, C. Picard-Dahan, V. Descamps & B. Crickx. (2007) Syndrome hémolytique et urémique et ischémie mésentérique aiguë lors d’un traitement par interféron alpha-2b pour une maladie de Kaposi associée au VIH. Annales de Dermatologie et de Vénéréologie 134:1, pages 65-67.
Crossref
Crossref
E. Oton, R. Barcena, J.M. Moreno-Planas, V. Cuervas-Mons, A. Moreno-Zamora, C. Barrios, S. Garcia-Garzon, A. Moreno, E. Boullosa-Graña, E.E. Rubio-Gonzalez, M. Garcia-Gonzalez, C. Blesa & M.L. Mateos. (2006) Hepatitis C Recurrence After Liver Transplantation: Viral and Histologic Response to Full-Dose Peg-Interferon and Ribavirin. American Journal of Transplantation 6:10, pages 2348-2355.
Crossref
Crossref
Claire Larroche. (2006) Complications vasculaires des affections hématologiques. EMC - Angéiologie 1:1, pages 1-5.
Crossref
Crossref
Sandy Srinivas. 2006. Oncology. Oncology
1435
1442
.
Nicoline Jochmann, Felix Kiecker, Adrian C Borges, Maja A Hofmann, Stephan Eddicks, Wolfram Sterry, Gert Baumann & Uwe Trefzer. (2005) Long-term therapy of interferon-alpha induced pulmonary arterial hypertension with different PDE-5 inhibitors: a case report. Cardiovascular Ultrasound 3:1.
Crossref
Crossref
Stefan Sleijfer, Marjolein Bannink, Arthur R. Gool, Wim H. J. Kruit & Gerrit Stoter. (2005) Side Effects of Interferon-α Therapy. Pharmacy World & Science 27:6, pages 423-431.
Crossref
Crossref
Doru T Alexandrescu, Prasad Maddukuri, Peter H Wiernik & Janice P Dutcher. (2005) Thrombotic Thrombocytopenic Purpura/Hemolytic Uremic Syndrome Associated with High-Dose Interleukin-2 for the Treatment of Metastatic Melanoma. Journal of Immunotherapy 28:2, pages 144-147.
Crossref
Crossref
Thierry Vial, Jacques Descotes, Felix Braun & Matthias Behrend. 2005. Side Effects of Drugs Annual 28. Side Effects of Drugs Annual 28
415
449
.
Claire Larroche. (2004) Complications vasculaires des affections hématologiques. EMC - Cardiologie-Angéiologie 1:4, pages 404-412.
Crossref
Crossref
Jeffrey S Dlott, Constance FM Danielson, Deborah E Blue-Hnidy & Leo J McCarthy. (2004) Drug-induced Thrombotic Thrombocytopenic Purpura/Hemolytic Uremic Syndrome: A Concise Review. Therapeutic Apheresis and Dialysis 8:2, pages 102-111.
Crossref
Crossref
. (2003) Current awareness: Pharmacoepidemiology and drug safety. Pharmacoepidemiology and Drug Safety 12:5, pages 431-446.
Crossref
Crossref
MERVYN KOH & RUSSELL K. PORTENOY. 2010. Cancer Pain. Cancer Pain
53
86
.